Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 2
Submit an article Journal homepage
402
Views
15
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

A lower dosage of imatinib is sufficient to maintain undetectable disease in patients with chronic myeloid leukemia with long-term low-grade toxicity of the treatment

Edgar FaberDepartment of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech RepublicCorrespondence[email protected]
,
Martina DivokáDepartment of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
,
Ivana SkoumalováDepartment of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
,
Martin NovákDepartment of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
,
Ivana MarešováDepartment of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
,
Kateřina MičováLaboratory for Inherited Metabolic Disorders, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
,
David FriedeckýLaboratory for Inherited Metabolic Disorders, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
,
Tomáš AdamLaboratory for Inherited Metabolic Disorders, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
,
Marie JarošováDepartment of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
&
Karel IndrákDepartment of Hemato-Oncology, University Hospital and Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czech Republic
 show all
Pages 370-375 | Received 26 Feb 2015, Accepted 23 May 2015, Published online: 22 Jun 2015
Supplemental material

ilal_a_1056184_sm6666.pdf

Download PDF (510.9 KB)

ilal_a_1056184_sm6667.pdf

Download PDF (510.9 KB)

ilal_a_1056184_sm6668.pdf

Download PDF (511.2 KB)

ilal_a_1056184_sm6669.pdf

Download PDF (510.9 KB)

ilal_a_1056184_sm6670.pdf

Download PDF (510.9 KB)

ilal_a_1056184_sm6671.pdf

Download PDF (510.9 KB)

ilal_a_1056184_sm6672.pdf

Download PDF (510.9 KB)

ilal_a_1056184_sm6673.pdf

Download PDF (510.9 KB)

ilal_a_1056184_sm6674.pdf

Download PDF (510.9 KB)

ilal_a_1056184_sm6675.pdf

Download PDF (510.9 KB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.